Marijuana Use: Difference between revisions
No edit summary |
No edit summary |
||
| (10 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Stub Notice}} | {{Stub Notice}} | ||
[https://pubmed.ncbi.nlm.nih.gov/36596580/ ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids] | |||
[https://pubmed.ncbi.nlm.nih.gov/35946907/ Paediatric cannabinoid hyperemesis] | [https://pubmed.ncbi.nlm.nih.gov/35946907/ Paediatric cannabinoid hyperemesis] | ||
| Line 8: | Line 10: | ||
[https://pubmed.ncbi.nlm.nih.gov/34042571/ Anesthesia for Patients Who Self-Report Cannabis (Marijuana) Use Before Esophagogastroduodenoscopy: A Retrospective Review] | [https://pubmed.ncbi.nlm.nih.gov/34042571/ Anesthesia for Patients Who Self-Report Cannabis (Marijuana) Use Before Esophagogastroduodenoscopy: A Retrospective Review] | ||
[https://www.apsf.org/article/perioperative-considerations-of-cannabis-use-on-anesthesia-administration/ APSF: Perioperative Considerations of Cannabis Use on Anesthesia Administration] | |||
[https://journals.lww.com/anesthesia-analgesia/fulltext/2024/01000/cannabis_and_cannabinoids_in_the_perioperative.4.aspx Cannabis and Cannabinoids in the Perioperative Period] | |||
[https://journals.lww.com/anesthesia-analgesia/fulltext/2024/01000/the_basic_science_of_cannabinoids.6.aspx The Basic Science of Cannabinoids] | |||
[https://journals.lww.com/anesthesia-analgesia/fulltext/2024/01000/an_overview_of_cannabidiol.7.aspx An Overview of Cannabidiol] | |||
[https://journals.lww.com/anesthesia-analgesia/fulltext/2024/01000/legal_and_regulatory_aspects_of_medical_cannabis.5.aspx Legal and Regulatory Aspects of Medical Cannabis in the United States] | |||
[https://pubmed.ncbi.nlm.nih.gov/38100796/ Cannabis as a Therapeutic or Snake Oil? A Call for Critical Appraisal of the Literature] | |||
References | |||
Shah S, Narouze S. Cannabis as a Therapeutic or Snake Oil? A Desperate Call for Critical Appraisal of the Literature. Anesthesia and analgesia 2024;138(1):2-4. (In eng). DOI: 10.1213/ane.0000000000006592. | |||
Sideris A, Lauzadis J, Kaczocha M. The Basic Science of Cannabinoids. Anesthesia and analgesia 2024;138(1):42-53. (In eng). DOI: 10.1213/ane.0000000000006472. | |||
Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol 2013;64:21-47. (In eng). DOI: 10.1146/annurev-psych-113011-143739. | |||
Turcotte C, Blanchet MR, Laviolette M, Flamand N. The CB(2) receptor and its role as a regulator of inflammation. Cell Mol Life Sci 2016;73(23):4449-4470. (In eng). DOI: 10.1007/s00018-016-2300-4. | |||
Araque A, Castillo PE, Manzoni OJ, Tonini R. Synaptic functions of endocannabinoid signaling in health and disease. Neuropharmacology 2017;124:13-24. (In eng). DOI: 10.1016/j.neuropharm.2017.06.017. | |||
Katona I, Freund TF. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 2008;14(9):923-30. (In eng). DOI: 10.1038/nm.f.1869. | |||
Piomelli D, Russo EB. The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis Cannabinoid Res 2016;1(1):44-46. (In eng). DOI: 10.1089/can.2015.29003.ebr. | |||
Anand U, Pacchetti B, Anand P, Sodergren MH. Cannabis-based medicines and pain: a review of potential synergistic and entourage effects. Pain management 2021;11(4):395-403. (In eng). DOI: 10.2217/pmt-2020-0110. | |||
Moore RA, Fisher E, Finn DP, et al. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews. Pain 2021;162(Suppl 1):S67-s79. (In eng). DOI: 10.1097/j.pain.0000000000001941. | |||
Haroutounian S, Arendt-Nielsen L, Belton J, et al. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. Pain 2021;162(Suppl 1):S117-s124. (In eng). DOI: 10.1097/j.pain.0000000000002266. | |||
Fisher E, Moore RA, Fogarty AE, et al. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain 2021;162(Suppl 1):S45-s66. (In eng). DOI: 10.1097/j.pain.0000000000001929. | |||
[https://academic.oup.com/pch/article/29/2/104/7641290 Medical cannabis for children: Evidence and recommendations] | |||
Shah S, Schwenk ES, Sondekoppam RV, et al. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg Anesth Pain Med. 2023 Mar; 48(3): 97-117. PMID: 36596580 | |||
Willer BL, Mpody C, Nafiu OO. Trends in Adolescent Comorbid Cannabis Use Disorder and Postoperative Complications. Pediatrics. 2024 Jun 1;153(6):e2024065757. doi: 10.1542/peds.2024-065757. PMID: 38708543. | |||
Willer BL, Mpody C, Nafiu OO. Trends in Adolescent Comorbid Cannabis Use Disorder and Postoperative Complications. Pediatrics 2024;153(6) (In eng). DOI: 10.1542/peds.2024-065757. | |||
2. Hashemi D, Gray K. Cannabis Use Disorder in Adolescents. The Psychiatric clinics of North America 2023;46(4):647-654. (In eng). DOI: 10.1016/j.psc.2023.03.013. | |||
3. Hasin DS, O'Brien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 2013;170(8):834-51. (In eng). DOI: 10.1176/appi.ajp.2013.12060782. | |||
4. Shah S, Schwenk ES, Sondekoppam RV, et al. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Regional anesthesia and pain medicine 2023;48(3):97-117. (In eng). DOI: 10.1136/rapm-2022-104013. | |||
5. Flannery KM, D'Souza G, Agarwal R. Perioperative Management of the Pediatric Patient on Medicinal Marijuana: What Anesthesiologists Should Know. Anesthesia and analgesia 2019;129(5):1339-1343. (In eng). DOI: 10.1213/ane.0000000000003956. | |||
6. Potnuru PP, Jonna S, Williams GW, 2nd. Cannabis Use Disorder and Perioperative Complications. JAMA surgery 2023;158(9):935-944. (In eng). DOI: 10.1001/jamasurg.2023.2403. | |||
7. Ding C, Xu D, Cheng T. Cannabis Use Disorder Associated With Increased Risk of Postoperative Complications After Hip or Knee Arthroplasties: A Meta-analysis of Observational Studies. The Journal of the American Academy of Orthopaedic Surgeons 2024 (In eng). DOI: 10.5435/jaaos-d-23-00407. | |||
See also [[Smoking and Vaping]] | See also [[Smoking and Vaping]] | ||
Latest revision as of 21:25, 17 August 2024
This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
Relevant Article Depot:
Paediatric cannabinoid hyperemesis
Pediatric Cannabinoid Hyperemesis: A Single Institution 10-Year Case Series
Cannabis, e-cigarettes and anesthesia
APSF: Perioperative Considerations of Cannabis Use on Anesthesia Administration
Cannabis and Cannabinoids in the Perioperative Period
The Basic Science of Cannabinoids
Legal and Regulatory Aspects of Medical Cannabis in the United States
Cannabis as a Therapeutic or Snake Oil? A Call for Critical Appraisal of the Literature
References Shah S, Narouze S. Cannabis as a Therapeutic or Snake Oil? A Desperate Call for Critical Appraisal of the Literature. Anesthesia and analgesia 2024;138(1):2-4. (In eng). DOI: 10.1213/ane.0000000000006592.
Sideris A, Lauzadis J, Kaczocha M. The Basic Science of Cannabinoids. Anesthesia and analgesia 2024;138(1):42-53. (In eng). DOI: 10.1213/ane.0000000000006472.
Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol 2013;64:21-47. (In eng). DOI: 10.1146/annurev-psych-113011-143739.
Turcotte C, Blanchet MR, Laviolette M, Flamand N. The CB(2) receptor and its role as a regulator of inflammation. Cell Mol Life Sci 2016;73(23):4449-4470. (In eng). DOI: 10.1007/s00018-016-2300-4.
Araque A, Castillo PE, Manzoni OJ, Tonini R. Synaptic functions of endocannabinoid signaling in health and disease. Neuropharmacology 2017;124:13-24. (In eng). DOI: 10.1016/j.neuropharm.2017.06.017.
Katona I, Freund TF. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 2008;14(9):923-30. (In eng). DOI: 10.1038/nm.f.1869.
Piomelli D, Russo EB. The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis Cannabinoid Res 2016;1(1):44-46. (In eng). DOI: 10.1089/can.2015.29003.ebr.
Anand U, Pacchetti B, Anand P, Sodergren MH. Cannabis-based medicines and pain: a review of potential synergistic and entourage effects. Pain management 2021;11(4):395-403. (In eng). DOI: 10.2217/pmt-2020-0110.
Moore RA, Fisher E, Finn DP, et al. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews. Pain 2021;162(Suppl 1):S67-s79. (In eng). DOI: 10.1097/j.pain.0000000000001941.
Haroutounian S, Arendt-Nielsen L, Belton J, et al. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. Pain 2021;162(Suppl 1):S117-s124. (In eng). DOI: 10.1097/j.pain.0000000000002266.
Fisher E, Moore RA, Fogarty AE, et al. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain 2021;162(Suppl 1):S45-s66. (In eng). DOI: 10.1097/j.pain.0000000000001929.
Medical cannabis for children: Evidence and recommendations
Shah S, Schwenk ES, Sondekoppam RV, et al. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg Anesth Pain Med. 2023 Mar; 48(3): 97-117. PMID: 36596580
Willer BL, Mpody C, Nafiu OO. Trends in Adolescent Comorbid Cannabis Use Disorder and Postoperative Complications. Pediatrics. 2024 Jun 1;153(6):e2024065757. doi: 10.1542/peds.2024-065757. PMID: 38708543.
Willer BL, Mpody C, Nafiu OO. Trends in Adolescent Comorbid Cannabis Use Disorder and Postoperative Complications. Pediatrics 2024;153(6) (In eng). DOI: 10.1542/peds.2024-065757.
2. Hashemi D, Gray K. Cannabis Use Disorder in Adolescents. The Psychiatric clinics of North America 2023;46(4):647-654. (In eng). DOI: 10.1016/j.psc.2023.03.013.
3. Hasin DS, O'Brien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 2013;170(8):834-51. (In eng). DOI: 10.1176/appi.ajp.2013.12060782.
4. Shah S, Schwenk ES, Sondekoppam RV, et al. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Regional anesthesia and pain medicine 2023;48(3):97-117. (In eng). DOI: 10.1136/rapm-2022-104013.
5. Flannery KM, D'Souza G, Agarwal R. Perioperative Management of the Pediatric Patient on Medicinal Marijuana: What Anesthesiologists Should Know. Anesthesia and analgesia 2019;129(5):1339-1343. (In eng). DOI: 10.1213/ane.0000000000003956.
6. Potnuru PP, Jonna S, Williams GW, 2nd. Cannabis Use Disorder and Perioperative Complications. JAMA surgery 2023;158(9):935-944. (In eng). DOI: 10.1001/jamasurg.2023.2403.
7. Ding C, Xu D, Cheng T. Cannabis Use Disorder Associated With Increased Risk of Postoperative Complications After Hip or Knee Arthroplasties: A Meta-analysis of Observational Studies. The Journal of the American Academy of Orthopaedic Surgeons 2024 (In eng). DOI: 10.5435/jaaos-d-23-00407.
See also Smoking and Vaping